Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Baker McKenzie Advises Joint Bookrunners on Sunway Healthcare’s MYR 3.28 Billion IPO

Дата публикации: 18-03-2026 00:00:00



Основное содержимое страницы с новостью.

Baker McKenzie acted as legal advisors to the Joint Global Coordinators and Joint Bookrunners, as to US federal securities laws and English law, in connection with the MYR 3.28 billion initial public offering (“IPO”) (including an over-allotment option) and the listing of Sunway Healthcare Holdings Berhad (“Sunway Healthcare”) on the Main Market of Bursa Malaysia. The listing is Malaysia’s largest initial public offering in almost a decade. The company’s shares commenced trading today.

Sunway Healthcare, a unit of Malaysian conglomerate Sunway Berhad, is one of Malaysia’s leading healthcare providers, operating 5 hospitals together with other ancillary healthcare businesses.

Maybank Investment Bank and AmInvestment Bank are the Joint Principal Advisers, Joint Global Coordinators, Joint Bookrunners, Joint Managing Underwriters and Joint Underwriters for the offering. UBS, HSBC and Jefferies also acted as Joint Global Coordinators, together with other Joint Bookrunners and Joint Underwriters in this international IPO, which included an offering to retail investors in Malaysia and institutional investors internationally in reliance on Regulation S under the U.S. Securities Act of 1933.

The Baker McKenzie deal team was led by US-qualified Capital Markets Principal Alexander Stathopoulos in Singapore*, supported by associates Natania Ng and Andre Sng. London-based Corporate Partner George Marshall, supported by associate Avni Devgan, advised on English law aspects of the IPO.

With one of the world’s largest capital markets practices, Baker McKenzie advises issuers, investment banks, financial sponsors, selling shareholders other market participants across the full spectrum of equity, debt and public and private market solutions, including IPOs, rights issues and other follow-on offerings, debt issuances and complex, multi-jurisdictional acquisitions and divestitures. Alexander and George have advised on many of the recent IPOs by Malaysian issuers with international placements.

Over the past three years, the Firm has advised on capital-raising matters across more than 40 stock exchanges worldwide and has been ranked for capital markets in more jurisdictions than any other by Chambers.

*Baker McKenzie Wong & Leow is the Singapore member firm of Baker McKenzie

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Baker McKenzie Advises Bain Capital Life Sciences on Investment in Swixx BioPharma01005-06-2026
2Baker McKenzie Advises Sino Biopharm on up to US$1.53 Billion Exclusive License Agreement with Sanofi for Rovadicitinib015.8812-03-2026
3Baker McKenzie Advises Bayer on USD 2.45 billion Acquisition of Perfuse Therapeutics018.3306-05-2026
4Baker McKenzie advises on the sale of Vitabiotics to Bain Capital01027-07-2026
5Baker McKenzie Advises Servier on the Acquisition of Day One Biopharmaceuticals for Approximately USD 2.5 Billion016.2510-03-2026
6Baker McKenzie Advises Chemomab on Merger with Scipher Medicine01010-07-2026
7Baker McKenzie Advises on Memo Therapeutics' Sale to Ipsen and Related Carve-Out018.3301-07-2026
8Baker McKenzie Advises a Consortium led by SPE Capital, and included EBRD, Proparco and BIO on their Investment in Leading Ophthalmic Pharmaceutical Manufacturer09.1501-04-2026
9Baker McKenzie Advises Merit Medical on the Acquisition of View Point Medical08.407-04-2026
10Baker McKenzie has advised STADA on the acquisition of rights to Locobase® from Karo Healthcare01005-05-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 18.33. Источник: www.bakermckenzie.com.